• Strategic and corporate advisory
• Equity story development
• IR strategy, planning & coordination
• HNW relationship development

Natasha is a commercially astute executive with excellent senior leadership and governance experience from an international corporate and consulting career in Europe and the U.S. She brings a proven track record in delivering sustainable growth in fast-paced regulated environments, including biotech, medtech and financial services. In her career, she led an internal IR function and delivered several successful financing rounds, including a Nasdaq IPO, as well as numerous strategic initiatives, corporate restructures, international expansions, industry partnerships and organizational scale-ups. Natasha is currently advising high net worth investors and also facilitates relationships with international family offices.